Stock listing

CAMX Stock Price, News, Filings & Events — Camurus Ab

Selected listing: CAMX · OMXSTO · SEK · SE

This page tracks Camurus Ab's CAMX:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CAMX:OMXSTO. CAMX:OMXSTO is the stock-level entry point for investors researching Camurus Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Camurus AB is a public company listed on the Swedish market under the ticker CAMX. The company has a market capitalization of approximately 3.99 billion SEK. Camurus focuses on developing innovative therapies for patients with serious diseases.

CAMX:OMXSTOSEKSEUpdated August 22, 2026
Camurus Ab logo
Ticker
CAMX:OMXSTO
Asset type
Stock
Market cap
$4.01B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
OMXSTO
Currency
SEK

Camurus Ab CAMX:OMXSTO stock context

This page tracks Camurus Ab's CAMX:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CAMX:OMXSTO. CAMX:OMXSTO is the stock-level entry point for investors researching Camurus Ab, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Camurus AB is a public company listed on the Swedish market under the ticker CAMX. The company has a market capitalization of approximately 3.99 billion SEK. Camurus focuses on developing innovative therapies for patients with serious diseases.

Latest news from Camurus Ab

All Camurus Ab news →

Camurus Ab earnings calls

Research Camurus Ab

Alternate listings